Tianjin Lisheng Pharmaceutical Co Ltd (002393) — Cash Flow Quality Index
Tianjin Lisheng Pharmaceutical Co Ltd (002393) has a Cash Flow Quality Index of 6.32x as of December 2025. Operating cash flow of CN¥287.81 Million exceeds net income of CN¥45.54 Million, indicating high earnings quality where cash backs reported profits. Explore 002393 long-term asset investment ratio to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Tianjin Lisheng Pharmaceutical Co Ltd Cash Flow Quality Index (2007–2025)
Historical Cash Flow Quality Index for Tianjin Lisheng Pharmaceutical Co Ltd across 19 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Tianjin Lisheng Pharmaceutical Co Ltd tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Tianjin Lisheng Pharmaceutical Co Ltd (2007–2025)
Year-by-year earnings quality comparison for Tianjin Lisheng Pharmaceutical Co Ltd. For live market cap and the full company financial profile, see Tianjin Lisheng Pharmaceutical Co Ltd market capitalisation.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.09x | CN¥451.85 Million | CN¥416.28 Million | ▲ +126.9% |
| 2024 | 0.48x | CN¥88.26 Million | CN¥184.53 Million | ▼ -17.4% |
| 2023 | 0.58x | CN¥209.51 Million | CN¥361.83 Million | ▼ -83.6% |
| 2022 | 3.54x | CN¥331.38 Million | CN¥93.61 Million | ▲ +120.2% |
| 2021 | 1.61x | CN¥196.34 Million | CN¥122.11 Million | ▼ -81.9% |
| 2020 | 8.86x | CN¥76.37 Million | CN¥8.62 Million | ▲ +521.5% |
| 2019 | 1.43x | CN¥268.33 Million | CN¥188.14 Million | ▲ +62.2% |
| 2018 | 0.88x | CN¥162.69 Million | CN¥184.98 Million | ▼ -42.7% |
| 2017 | 1.53x | CN¥179.25 Million | CN¥116.82 Million | ▲ +2.2% |
| 2016 | 1.50x | CN¥173.60 Million | CN¥115.61 Million | ▼ -13.4% |
| 2015 | 1.73x | CN¥198.13 Million | CN¥114.22 Million | ▲ +123.0% |
| 2014 | 0.78x | CN¥72.24 Million | CN¥92.89 Million | ▼ -20.0% |
| 2013 | 0.97x | CN¥289.62 Million | CN¥298.06 Million | ▲ +16.9% |
| 2012 | 0.83x | CN¥250.72 Million | CN¥301.74 Million | ▲ +105.8% |
| 2011 | 0.40x | CN¥134.58 Million | CN¥333.39 Million | ▼ -52.6% |
| 2010 | 0.85x | CN¥186.55 Million | CN¥219.26 Million | ▼ -27.9% |
| 2009 | 1.18x | CN¥196.14 Million | CN¥166.25 Million | ▲ +33.7% |
| 2008 | 0.88x | CN¥126.59 Million | CN¥143.46 Million | ▼ -33.4% |
| 2007 | 1.33x | CN¥174.94 Million | CN¥131.95 Million | — |